Markov Models in TreeAge Pro

Build Sophisticated Markov Models Visually

Build health states and patient pathways in a visual modeling environment, then analyze disease progression, costs, outcomes, and uncertainty with integrated health economic analysis tools.

Build Visually

Analyze with Confidence

Communicate Clearly

  • Communicate your model, assumptions, and results clearly with visual model structure and integrated reporting.

Build Your Markov Model Structure

Health States and Event Pathways

Build health states and event pathways directly in the visual model editor.

Use the Markov Model Building Wizard to define the main structure of your Markov model.

Markov Structure

Add Inputs Where They Apply

Add Event Probabilities

Add event and transition probabilities directly to the model to define how patients move between health states over time

Use hazard functions to represent how event risk changes over time.

Use Patient Simulation when patient characteristics and history influence disease progression and outcomes.

Add Costs and Utilities

Add costs and utilities to health states and events so economic outcomes and health-related quality of life follow the patient pathways represented in the model.

Track additional clinical and model outcomes, such as progressions, deaths, screenings, and procedures, as patients move through the model.

Analyze Your Markov Model with Built-In Tools

Markov Model Calculations & Reporting

Model calculations follow the health states, events, probabilities, costs, and utilities you define within the model structure. Results include costs, effectiveness, and other outcomes used in cost-effectiveness analysis.

Markov Cohort Reports provide cycle-by-cycle details on disease progression, health-state membership, costs, utilities, and other outcomes.

Built-in functions support half-cycle correction and discounting within the Markov process.

Markov Cohort Report

Markov Plot

Use the Markov Plot to compare disease progression in your model with clinical Kaplan-Meier survival curves.

Refine model assumptions and compare updated model behavior with the clinical evidence.

Extend Your Markov Analysis

Use integrated health economic analysis tools to explore results and uncertainty within your Markov model.

Communicate and Share Your Model

Make your Markov model and results easier for colleagues, clients, and reviewers to explore and understand.

State Transition Diagrams

Convert your Markov model to a State Transition Diagram to provide a simplified visual representation of health states and transitions for presentations, reports, and publications.

Start with a State Transition Diagram to establish the flows among states, then convert it to the tree format to add inputs and complexity.

State Transition Diagrams show the flow among states in an easily understandable format.

Learn More About Markov Modeling in TreeAge Pro

Markov Model Webinar

See how to build, analyze, and explore Markov models in TreeAge Pro using the visual modeling framework and integrated analysis and reporting tools.

Build a Markov Model Visually

Analyze a Markov Model

What Is a Markov Model and Why Is It Used in Health Economics?

Markov models, also known as state transition models, represent disease progression over time using a defined set of health states and transitions between them.

For example, a cancer model might include health states such as progression-free disease, progressed disease, and death. During each model cycle, patients can remain in their current health state or transition to another state based on defined probabilities. Repeating this process over time represents how the patient population progresses through the model.

As patients move through the model, costs, utilities, and other outcomes can be associated with health states and events. This allows the model to accumulate clinical and economic outcomes over the selected time horizon.

Markov cohort analysis tracks the proportion of the patient cohort in each health state over time and calculates the resulting costs, effectiveness, and other outcomes. These results can then be used to compare alternative strategies through cost-effectiveness and other health economic analyses.